Answers are grounded in this paper and cite their sources.
Diagnostic evaluation demonstrates dual-phase PET-mpMRI potential in post-radiotherapy brain tumour patients, highlighting improved differentiation.
Brain metastases or primary brain tumours had poor prognosis until the use of high dose radiotherapy. However, radionecrosis is a complex challenge in the post-radiotherapy management of these patients due to the difficulty of distinguishing this complication from local tumour recurrence. MRI alone has a variable specificity and sensibility, as does PET-CT imaging. We aimed to investigate the diagnostic performance of dual-phase
No takes yet. Share an insight, caveat, or question.
Cailleteau et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: